Herpes simplex encephalitis

Herpes simplex encephalitis, often called HSE, is a severe infection of the brain. It is caused by the herpes simplex virus. This condition is a serious medical emergency because it affects how the brain functions. It is estimated to affect at least 1 in 500,000 individuals every year. Some studies show an incidence rate of 5.9 cases per 100,000 live births. While many people carry the herpes virus, only a small number develop this specific brain inflammation.

The mechanism of the disease involves the movement of the virus through the nervous system. Scientists believe the virus may start at a peripheral site on the face. This often happens after the reactivation of the herpes simplex virus-1 (HSV-1). The virus may travel along a nerve axon to reach the brain. It is thought to lie dormant in the ganglion of the trigeminal cranial nerve. The olfactory nerve might also play a role in this process. This nerve sends branches to the temporal lobes, which may explain why the virus targets those specific areas.

There are different types of the virus that cause HSE. About 90% of cases are caused by HSV-1. This is the same virus that typically causes cold sores. Interestingly, 57% of American adults are infected with HSV-1, but most never get cold sores. The other 10% of HSE cases are caused by HSV-2. While HSV-1 is the most common cause for children and adults, HSV-2 is the main cause for newborns and immunocompromised individuals.

Doctors look for specific signs to identify the illness. Patients often show a decrease in consciousness or an altered mental state. This can include confusion or sudden changes in personality. Many people also experience a fever or seizures. As the disease progresses, the electrical activity in the brain changes. It usually shows abnormalities in one temporal lobe first. These abnormalities then spread to the other temporal lobe about 7 to 10 days later. Some patients may also lose their sense of smell or struggle to speak and read.

To make a definite diagnosis, doctors must test the cerebrospinal fluid (CSF). They do this through a procedure called a lumbar puncture, or a spinal tap. This test looks for the presence of the virus itself. Because these tests can take several days, doctors often start treatment immediately. They use a medicine called acyclovir, which is given as a high-dose intravenous infusion. For adults, the dose is 10 mg/kg infused over one hour to prevent kidney failure.

The statistics regarding survival and recovery show why quick action is vital. Without treatment, HSE results in rapid death in approximately 70% of cases. Even with treatment, the disease remains fatal in one-third of patients. Over half of the survivors face serious, long-term neurological damage. However, 20% of treated patients recover with only minor damage. Only a very small group of 2.5% of untreated survivors regain completely normal brain function. Starting treatment within 48 hours of the first symptoms improves the chances of recovery.

HSE is also linked to other complex medical conditions. For example, it can serve as a trigger for anti-NMDA receptor encephalitis. About 30% of HSE patients develop this secondary immune reaction. This reaction is associated with impaired neurocognitive recovery. Additionally, the virus can cause abnormal inflammation in the brain. This is known as granulomatous inflammation, which can respond to steroids. While the virus itself can spread between people, the encephalitis condition is not infectious.